Compare OBDC & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBDC | HAE |
|---|---|---|
| Founded | 2015 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.4B |
| IPO Year | 2015 | 1996 |
| Metric | OBDC | HAE |
|---|---|---|
| Price | $10.48 | $119.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $13.10 | ★ $124.50 |
| AVG Volume (30 Days) | ★ 4.2M | 673.9K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 11.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.08 | ★ 0.72 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | N/A | $6.21 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | ★ $131.69 | $167.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.81 | $49.96 |
| 52 Week High | $13.58 | $123.77 |
| Indicator | OBDC | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 64.21 |
| Support Level | $9.81 | $115.49 |
| Resistance Level | $11.37 | $122.84 |
| Average True Range (ATR) | 0.22 | 2.86 |
| MACD | 0.09 | -0.37 |
| Stochastic Oscillator | 83.06 | 70.15 |
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.